Philip Morris
Nicotine Infused Into the Nucleus Accumbens Increases Synaptic Dopamine As Measured by in Vivo Microdialysis
Fields
- Author
- Hernandez, L.
- Hoebel, B.G.
- Mifsud, J.C.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- Area
- WORLDWIDE REG AFFAIRS/LIBRARY
- Site
- N403
- Named Organization
- Bgh
- Rhone Poulenc
- Named Person
- Davidson, D.
- Kellar, K.
- Request
- Stmn/R1-036
- Stmn/R1-072
- Stmn/R1-073
- Stmn/R4-005
- Author (Organization)
- Princeton Univ
- Master ID
- 2046398862/0490
- 2046398862-8874 Submission of Phillip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Iots Meeting on 940802 Volume 3.01
- 2046398875 2
- 2046398876-8886 Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Dsm-IV
- 2046398887 3
- 2046398888-8892 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition - Revised) Dsm-III-R
- 2046398893 4
- 2046398894-8897 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition)
- 2046398898 5
- 2046398899-8901 What Makes US Run?
- 2046398902 6
- 2046398903-8931 Chapter 5 the Neurochemical Mechanisms Underlying Nicotine Tolerance and Dependence
- 2046398932 7
- 2046398933-8994 8. The Psychopharmacological and Neurochemical Consequences of Chronic Nicotine Administration
- 2046398995 8
- 2046398997-8999 Establishing A Nicotine Threshold for Addiction
- 2046399000 9
- 2046399001-9006 Intravenous Nicotine Replacement Suppresses Nicotine Intake From Cigarette Smoking
- 2046399007 10
- 2046399008-9013 Daily Intake of Nicotine During Cigarette Smoking
- 2046399014 11
- 2046399015-9022 Stable Isotope Studies of Nicotine Kinetics and Bioavailability
- 2046399023 12
- 2046399024-9060 Biobehavioral Approaches to Smoking Control
- 2046399061 13
- 2046399062-9064 Brief Communication Preference Among Research Cigarettes with Varying Nicotine Yields
- 2046399065 14
- 2046399066-9076 Slip-Ups and Relapse in Attempts to Quit Smoking
- 2046399077 15
- 2046399078-9100 Drug Addiction As A Psychological Process
- 2046399101 16
- 2046399102-9113 Population Characteristics and Cigarette Yield As Determinants of Smoke Exposure
- 2046399114 17
- 2046399115-9123 Smoking History, Cigarette Yield and Smoking Behavior As Determinants of Smoke Exposure.
- 2046399124 Andrews Office Products Capitol Heights, Md (K) 18
- 2046399125-9216 Out of the Shadows Understanding Sexual Addiction Second Edition
- 2046399217 Andrews Office Products Capitol Heights, Md (K) 19
- 2046399218-9220 Morbidity and Mortality Weekly Report Progress in Chronic Disease Prevention Smoking Cessation During Previous Year Among Adults - United States, 900000 and 910000
- 2046399221 Andrews Office Products Capitol Heights, Md (K) 20
- 2046399222-9224 Research Report Can Carrots Be Addictive? An Extraordinary Form of Drug Dependence
- 2046399225 Andrews Office Products Capitol Heights, Md (K) 21
- 2046399226-9233 Running Addiction: Measurement and Associated Psychological Characteristic
- 2046399234 Andrews Office Products Capitol Heights, Md (K) 22
- 2046399235-9252 Goth's Medical Pharmacology
- 2046399253 Andrews Office Products Capitol Heights, Md (K)
- 2046399254-9272 An Analysis of the Addiction Liability of Nicotine
- 2046399273 Andrews Office Products Capitol Heights, Md (K) 24
- 2046399274-9283 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399284 Andrews Office Products Capitol Heights, Md (K) 25
- 2046399285-9288 the Effect of Running on Plasma Beta-Endorphin
- 2046399289
- 2046399290 Library Copy: Please Return
- 2046399291 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.02
- 2046399292 21 Andrews Office Products Capitol Heights, Md (K)
- 2046399293-9300 Running Addiction: Measurement and Associated Psychological Characteristics
- 2046399301 22 Andrews Office Products Capitol Heights, Md (K)
- 2046399302-9319 Goth's Medical Pharmacology Drug Abuse and Dependence
- 2046399320 23 Andrews Office Products Capitol Heights, Md (K)
- 2046399321-9339 An Analysis of the Addiction Liability of Nicotine
- 2046399340 24 Andrews Office Products Capitol Heights, Md (K)
- 2046399341-9350 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399351 25 Andrews Office Products Capitol Heights, Md (K)
- 2046399352-9355 the Effect of Running on Plasma B-Endorphin
- 2046399356 26 Andrews Office Products Capitol Heights, Md (K)
- 2046399357-9375 Shopaholics Serious Help for Addicted Spenders Chapter 3 Nature of Addiction
- 2046399376 27 Andrews Office Products Capitol Heights, Md (K)
- 2046399377-9380 Effect of Transdermal Nicotine Delivery As An Adjunct to Low-Intervention Smoking Cessation Theraphy
- 2046399381 28 Andrews Office Products Capitol Heights, Md (K)
- 2046399382-9394 Measuring Nicotine Dependence: A Review of the Fagerstrom Tolerance Questionnaire
- 2046399395 29
- 2046399396-9419 Tolerance Withdrawal and Dependence on Tobacco and Smoking Termination
- 2046399420 30 Andrews Office Products Capitol Heights, Md (K)
- 2046399421-9426 Methods Used to Quit Smoking in the United States Do Cessation Programs Help?
- 2046399427 31 Andrews Office Products Capitol Heights, Md (K)
- 2046399428-9434 Effect of Transdermal Nicotine Patches on Cigarette Smoking A Double Blind Crossover Study
- 2046399435 32
- 2046399435A Symposium Smoking Cessation: A Comparison of Aided Vs. Unaided Quitters / Attempters. Predictors of Early Relapse.
- 2046399436 33
- 2046399437-9448 Mind Matters How Mind and Brain Interact to Create Our Conscious Lives
- 2046399449 34
- 2046399450-9452 Cigarette Craving, Smoking Withdrawal, and Clonidine
- 2046399453 35
- 2046399454-9456 Psycological and Pharmacological Influences in Cigarette Smoking Withdrawal: Effects of Nicotine Gum and Expectancy on Smoking Withdrawal Symptoms and Relapse
- 2046399457 36
- 2046399458-9463 Crs Report for Congress Cigarette Taxes to Fund Health Care Reform: An Economic Analysis
- 2046399464 37
- 2046399465-9472 22.4 Caffeine and Tobacco Dependence
- 2046399473 38
- 2046399474-9476 Pinball Wizard: the Case of A Pinball Machine Addict
- 2046399477 39
- 2046399478-9492 Reviews Caffeine Physical Dependence: Review of Human and Laboratory Animal Studies
- 2046399493 40
- 2046399494-9498 Brief Report Reactions to Withdrawal Symptoms and Success in Smoking Cessation Clinics
- 2046399499 41
- 2046399500-9505 Nicotine or Tar Titration in Cigarette Smoking Behavior?
- 2046399506 42
- 2046399507-9511 Brief Report Blood Nicotine, Smoke Exposure and Tobacco Withdrawal Symptoms
- 2046399512 43
- 2046399513-9523 Conference Report Involvement of Tobacco in Alcoholism and Illicit Drug Use
- 2046399524 44
- 2046399525-9535 Pharmacologic Basis and Treatment of Cigarette Smoking
- 2046399536 45
- 2046399537-9550 'chocolate Addiction': A Preliminary Study of Its Description and Its Relationship to Problem Eating
- 2046399551 46
- 2046399552-9562 Smoking Cessation Methods: Recommendations for Health Professionals. Advisory Group of the European School of Oncology
- 2046399563 47
- 2046399564-9574 Nicotine Yield As Determinant of Smoke Exposure Indicators and Puffing Behavior
- 2046399575 48
- 2046399576-9581 Psychological Analysis of Establishment and Maintenance of the Smoking Habit
- 2046399582 49
- 2046399583-9586 Seminars in Respiratory Medicine Appetitive Functions and Dysfunctions: Tobacco
- 2046399587 Andrews Office Products Capitol Heights, Md (K)
- 2046399588 Endorphins, Eating Disorders and Other Addictive Behaviors
- 2046399589-9621 the Clinical Phases of Anorexia Nervosa and Their Relevance to Endorphin Addiction
- 2046399622 51
- 2046399623-9632 Pharmacotheraphy for Smoking Cessation: Unvalidated Assumptions, Anomalies, and Suggestions for Future Research
- 2046399633 52
- 2046399634-9641 Risk - Benefit Assessment of Nicotine Preparations in Smoking Cessation
- 2046399642 53
- 2046399643-9650 Should Caffeine Abuse, Dependence, or Withdrawal Be Added to Dsm - IV and Icd - 10?
- 2046399651 54
- 2046399652-9660 Tobacco Withdrawal in Self - Quitters
- 2046399661 55
- 2046399662-9669 Symptoms of Tobacco Withdrawal A Replication and Extension
- 2046399670
- 2046399671-9763 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.03 Effects of Abstinence From Tobacco A Critical Review
- 2046399764 57
- 2046399765-9769 Reports From Research Centres - 21 Human Behavioral Pharmacology Laboratory University of Vermont
- 2046399770 58
- 2046399771 Withdrawal Symptoms and Smoking Cessation
- 2046399772 59
- 2046399773-9778 Nicotine Vs Placebo Gum in General Medical Practice
- 2046399779 60
- 2046399780-9783 Prevalence of Tobacco Dependence and Withdrawal
- 2046399784 61
- 2046399785-9790 Signs and Symptoms of Tobacco Withdrawal
- 2046399791 62
- 2046399792-9798 Patterns and Predictors of Smoking Cessation Among Users of A Telephone Hotline
- 2046399799 63
- 2046399800-9820 Current Concepts of Addiction
- 2046399821 64
- 2046399822-9861 the American Academy of Psychiatrists in Alcoholism and Addictions 910000 Annual Meeting
- 2046399862 65
- 2046399863-9915 the Pharmacological Basis of Therapeutics Eighth Edition Chapter 22 Drug Addiction and Drug Abuse
- 2046399916 66
- 2046399917-9953 1 Tobacco Smoking and Nicotine Dependence
- 2046399954 67
- 2046399955-9957 Commentary Trivializing Dependence
- 2046399958 68
- 2046399959-9968 the Favorite Cigarette of the Day
- 2046399969 69
- 2046399970-9971 Overview: Alternative Forms of Pharmacologic Treatment
- 2046399972 70
- 2046399973-9974 British Medical Journal No 6891 Volume 306
- 2046399975 71
- 2046399976-9981 Original Contributors Predicting Smoking Cessation Who Will Quit with and Without the Nicotine Patch
- 2046399982 72
- 2046399983-0019 the Selling of Dsm the Rhetoric of Science in Psychiatry
- 2046400020 73
- 2046400021-0028 the Nosology of Abuse and Dependence
- 2046400029 74
- 2046400030-0035 Use and Misuse of the Concept of Craving by Alcohol, Tobacco, and Drug Researchers
- 2046400035A
- 2046400036-0045 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802
- 2046400046 75
- 2046400047-0048 What Researchers Make of What Cigarette Smokers Say: Filtering Smokers' Hot Air
- 2046400049 76
- 2046400050-0055 the Use of Flavor in Cigarette Substitutes
- 2046400056 77
- 2046400057-0060 Failure to Support the Validity of the Fagerstrom Tolerance Questionnaire As A Measure of Physiological Tolerance to Nicotine
- 2046400061 78
- 2046400062-0067 Effects of Cigarette Smoking on Electrodermal Orienting Reflexes to Stimulus Change and Stimulus Significance
- 2046400068 79
- 2046400069-0074 Behavioral (Non-Chemical) Addictions
- 2046400075 80
- 2046400079 81
- 2046400080-0085 the Chemistry of Craving
- 2046400086 82
- 2046400087-0102 the Disease Controversy Revisited: An Ontologic Perspective
- 2046400103 83
- 2046400104-0134 A Psychopharmacological and Psychophysiological Evaluation of Smoking Motives
- 2046400135 84
- 2046400136-0146 Predictors and Reasons for Relapse in Smoking Cessation with Nicotine and Placebo Patches
- 2046400147 85
- 2046400148-0155 Clinical Trials and Therapeutics Nasal Spray Nicotine Replacement Suppresses Cigarette Smoking Desire and Behavior
- 2046400156 86
- 2046400157-0163 Predictors of Smoking Cessation in A Sample of Italian Smokers
- 2046400164 87
- 2046400165-0167 Clarification and Standardization of Substance Abuse Terminology
- 2046400168 88
- 2046400169-0179 the Role of Nicotine in Tobacco Use
- 2046400180 89
- 2046400181-0186 Pharmacoepidemiology and Drug Utilization How the Steady - State Cotinine Concentration in Cigarette Smokers Is Directly Related to Nicotine Intake
- 2046400187 90
- 2046400188-0192 Transdermal Nicotine As A Strategy for Nicotine Replacement
- 2046400193
- 2046400194-0198 Sensory Blockade of Smoking Satisfaction
- 2046400199 92
- 2046400200-0204 Brief Report Subjective Response to Cigarette Smoking Following Airway Anesthetization
- 2046400205 93
- 2046400206-0212 Intervention Strategies for Smoking Cessation the Role of Oncology Nursing
- 2046400213 94
- 2046400214-0219 Reduction of Tar, Nicotine and Carbon Monoxide Intake in Low Tar Smokers
- 2046400220 95
- 2046400221-0234 Long-Term Switching to Low-Tar Low-Nicotine Cigarettes
- 2046400235 96
- 2046400236-0239 Comment Recidivism and Self-Cure of Smoking and Obesity: An Attempt to Replicate
- 2046400240 97
- 2046400241-0249 Recidivism and Self-Cure of Smoking and Obesity
- 2046400250 98
- 2046400251-0263 Public Forum Love: Addiction or Road to Self-Realization, A Second Look
- 2046400264 99
- 2046400265-0274 Pharmacological and Non-Pharmacological Smoking Motives: A Replication and Extension
- 2046400275 100
- 2046400276-0289 Overcoming the Loss of A Love: Preventing Love Addiction and Promoting Positive Emotional Health
- 2046400290 101
- 2046400291-0298 the Health Benefits of Smoking Cessation A Report of the Surgeon General
- 2046400299 102
- 2046400300-0338 the Health Consequences of Smoking Nicotine Addiction A Report of the Surgeon General
- 2046400339 103
- 2046400340-0357 the Health Consequences of Smoking Chronic Obstructive Lung Disease A Report of the Surgeon General Chapter 6. Low Yield Cigarettes and Their Role in Chronic Obstructive Lung Disease
- 2046400358 104
- 2046400359 Smoking and Health Report of the Advisory Committee to the Surgeon General of the Public Health Service
- 2046400360-0369 Chapter 13 Characterization of the Tobacco Habit
- 2046400370 105
- 2046400371-0375 Is Nicotine Use An Addiction
- 2046400376 106
- 2046400377-0391 Nicotine Pharmacodynamics: Some Unresolved Issues
- 2046400392 107
- 2046400393-0400 Craving for Cigarettes
- 2046400401 108
- 2046400402 Smoker Motivation A Review of Contemporary Literature
- 2046400403-0453 Chapter 1 Trends in Cigarette Consumption and the Sociodemographic Structure of the Smoking Population in Developed Industrial Countries
- 2046400454 109
- 2046400455-0461 Increase of Circulating Beta-Endorphin-Like Immunoreactivity Correlates with the Change in Feeling of Pleasantness After Running
- 2046400462 110
- 2046400463-0469 New Data Note Series - 20 Severity of Dependence: Data From the Dsm-IV Field Trials
- 2046400470 111
- 2046400471-0479 World Health Organization Technical Report Series No. 551 Who Expert Committee on Drug Dependence Twentieth Report
- 2046400480 112
- 2046400481-0489 Cigarette Brand-Switching: Effects on Smoke Exposure and Smoking Behavior
- 2046400490
Related Documents:
Document Images
I
I
I
I
I
Elsvur
Brmn Research, 4*-1989) 36-5-3G7 365
BRE ?3320
Nicotine infused into the nucleus accumbens increases synaptic
dopamine as measured by in vivo microdialysis
Jean-Christophe Mifsud, Luis Hernandez and Bartley G. Hoebel
DtpernnenroJPr,vcholo;s, Princaon Univerriry, Prusceton, Nl0dS44-1010(U.S.A.)
( Acapted 11 October 1988)
Key words: Nicotine: Dopamme: Microdialysis: Nudeus accvmbens; Addiction
I
1
I
I
I
I
I
I
I
It has been postulated that addiction to nicotine is mediated by dopanune release in the mesolimbic
system. It is possible that nico-
tine mtght act directly on the dopamtne terminals to releax dopamtne. This hypothesis was tested by
infuutl ntconne through a nu-
crodulysis probe into the nucleus accumbens of freely moving rats. Dopamine. dihydroxyphenyiaeetx
sad. and homovantllic acid
from the extrarellular space were collected by mtcrodulysis and measured by high pressure liquid
chtornatognph,v. Nicotine tn
creased extracellular oopamine in a dose-related manner. Systemic injection of the nkotine anugottut
mecamylatntne blocked the
dopamtne increase induced by local nicotnx. These results suggest that nicotitx releases dopatnine
by a local action in the nucleus ac-
cumbens tertainal area of the mesolunbic system. Presynapttc tnducuon of dopanune release enight
play a rok in oxonne addiction.
Nicotine is an alkaloid naturally occurring in to-
bacco leaves's. It is a primary reinforcer self-adminis-
tered by humans and other animals as well7. This
property seems to be centrally mediated by catechol-
amines. Nicotine releases norepinephrine and dopa-
mine from brain siices'-19. Rats self-inject ampheta-
mine which releases dopamine and self-inject dopa-
mine itself into the nucleus accttmbens°". There
fore. a local action of nicotine to release dopamine in
the atxumbens might play an important role in nico-
tine self-administration. Microdialysis studies have
shown that systemic administration of nicotine in-
creases extncellular dopamine in the nucleus atcvm-
bens of freely moving ratsu. This systemic effect
might be due to a direct action of nicotine on dopa-
mine terminals. To test this proposition we have stud-
ied the effect of niootine on dopamine release by di-
rect application of the drug to the nucleus aavm-
bens. Microdialysis probes were used both for drug
infusion and neurochemical sampling in freely mov-
ing animalsi'.
Twenty-six male Sprague-Dawley rats (250-300 g)
were individually housed with food and water ad libi-
tum. Under pentobarbital (23 mg/kg) and ketamine
(Ketalar, 57 mg/kg) anesthesia, a 10 mm long 21-
gauge guide cannula was implanted in the posterior
region of the nucleus accurnbens medial to the ante-
rior cornmissure. With the skull level the coordinates
were 10.0 mm anterior to the interaural line, 1.2 mm
lateral to the midsagittal suture, and 4.0 mm ventral
to the surface of the skull. Experiments were per-
formed at least 48 h after the implantation of the
guide shaft. The microdialysis probes were con-
stntcted of concentric 36-gauge stainless steel tubing
inside of 26-gauge tubing, ending in a 3 tnm tip ot0.2
mm outside diameter cellulose tubing with a 6000
mol. wt. cut-offu. Ringer's solution was pumped
through the microdialyztis probe at a flow of Iol/min.
These probes have a relative recovery of 5-10% at a
flow rate of 1 µl/minu. On the day of perfusion, a
probe was inserted into the guide shaft and con-
nected to the syringe pump and a 4001r1 polyethylene
vial for collecting the output. Starting after 1 b, sam-
pks were collected every 20 min in 400 µl vials corl-
taining 10 NI of 0.1 N HC1 and 100 µM EDTA to re-
tard oxidation of monoamines. Dopamine (DA) and
the metabolites dihydroxyphenyiacstic acid (DOPAC)
and homovanillic acid (HVA) were separated by re-
Co.respondrnn: B.G. Hoebel. Deparunertt of hycNology, Prittatoa University, Prittcetoo, NJ
065441010. U.S.A.
0D06-tt993JE9/S03.50®19E9 Elsevier Science Publishers B.V. (Biomedical Division)

I
~
I
I
I
I
I
I
i
I
I
I
I
~
I
I
,
366
verse phase liquid chromatography according to the
procedures described elsewhere (Hernandez et ai.,
1986). The sample was directly injected into an
HPLC equipped with a 20,u1 injection loop and 10 cm
long, 3.2 mm bore, 3,um particle, C-1S column. The
chemicals were electrochemically detected in an am-
perometric detector (BAS Co., Model LC-4B) by
oxidation on a glassy carbon electrode at 0.71 V with
respect to an Ag-AgCI reference electrode. When
stable levels of chemicals were observed a 30 cm
piece of PE-10 tubing was fully loaded with 20 µl of
2.4 µM nicotine solution and intercalated into the in-
put line. This allowed gentle application of nicotine
into the nucleus accumbens for 20 min without me-
chanical disturbance of the tissue. Nicotine diffused
out of the probe at the same time DA, DOPAC, and
HVA diffused along their concentration gradients.
For a dose-response curve the monoamine data
were plotted directly in terms of picdtrams per 100
min (5 samples following the injection). For the rest
of the experiments the data were normalized as per-
cent of the first baseline sample and then analyzed by
ANOVA followed by Newman-Keuts test when war-
ranted.
In the first experiment 4 rats were used to establish
the phenomenon. As shown in Fig. 1, the 2.4µM nic-
otine dose stimulated DA release by 490% (Fr,7t -
20.5, P < 0.001). The dopamine level reached its
maximum 40 min after the beginning of the 20-min
perfusion period and returned to the initial baseline
60 min later. No dartge in DOPAC or HVA oc
ctured. In the second experiment with 16 rats, 4 more
doses of nicotine, two higher aad two {ower, were
each infused in 4 naive rats to aeate a dose-response
A
+ :e
MINUTES
®
. Fig. 1. Aa infusiott M 2.4MM ttioonne in the period iadiaatsd by
tbe arto.vs maeised doQantine in the earsoeUular ooaapart.
' taent of the audetn aocutntxo: (meae t S.E.M.. 01 a 4,
Pc0.001)ia4rats.
.
J.i. .
NICOTINE
4+IA)
.
Fig. 2. Dose-response reiationship between nicotitte cottan
tration put into the infu:ate for 20 nun and DA eoneentrauon
recovered dunng the sutuquent 100 min. The Unear eorrela-
twn of 0.79 was stgnificant ( P< 0.05).
curve. Fig. 2 suggests a sigmoidal relationship be-
tween nicotine concentration and extracelhilar DA.
The regression analysis showed a significantly linear
correlation between nicotine dose and extracellular
dopamine (F., - 11.26, P < 0.05).
Specificity of the stimulatory effect of nicotine on
DA release was tested with a nicotinic receptor
blocker. In 6 rats nicotine solution (2.4,uM) was in-
fused twice 160 min apart. Half the animals were in-
jeaed s.c. with 1 mg/kg of inecatnylamine hydrochlo-
ride 40 tnin before the second infusion. Results of this
experiment show that the first infusion of nicotine in-
creased dopamine in all 6 rats. In the control condi-
tion without meamyiamine, the second infusion of
~
$
rMMIANR.~
tM aM aM M M
FiS. 3. Sqstetaic meamytamine b{oets local ttiaodae effea oa
enraaUutar DA ia tbe arodetat aowaobea. Six rats wm Rvea
a 20 ttsia lod 'tnfnt+ioe of tncooae (open yuats. aeae t
S.E.M. ). T3ea 3 of tbem teoeived an s.e. iajaetioa of tbe arta
tiaie t,iodter meeaaaytamine fotio.ed 40 =a Wer by a ncoed
loal inftaioo of t3icodne (blaek t4rslM). The txber 3 rats (opes
tarda) did not reoeive meamylamia. Poiats with anwislts
rere sipti5caady peater than b.aeiiae. Meet+myiamiee, i.p..
r+pti6caatty aataaoeixd the doQamioe-releatiaS etIaa ot loo!
amootiae (P < 0.01).

I
I
I
I
~
i
I
I
I
I
I
I
1
I
I
I
I
I
nicotine had somewhat less effect than the first infu-
sion (first nicotine produced 476% DA, n= 6, vs sec
ond nicotine 390% DA, n - 3, not significant). In the
group of 3 that received systemic mecamylamine, the
second infusion of nicotine increased extracellular
dopamine only 10% (i.e. DA 110% of baseline with
nicotine plus blocker vs 390% without the blocker,
F1,4 - 25.89, P< 0.01). Histological examination
showed tracks of the probes in the intended posterior
region of the nucleus aocumbens medial to the ante-
rior commissure.
These experiments extend previous microdialysis
results which showed that systemic nicotine increases
exaracellular doparnine in the nucleus accumbensls
Tte present results suggest that nicotine relaases
dopamine by acting locally via the dopamine tettni-
tlals in the nucleus accumbens. This effect was sup-
pressed by pretreatment with meanzylamine, a nic-
otinic cholinergic receptor blocker. Therefore it ap
pears that the release of DA induced by nicotine can
have its origin in centrally located nicotinic choliner-
gic recepton172Q. These receptors have besn de
scribed as specific binding sites for nicotine. Our re-
I Arguero. L., Naguira, D. and Z.unino, E., NKocinein-
duoed release of catecAolatnines from rat hippocampus and
strtattun, siothent. Pbenn.col., 2r (1978) 2667-2674.
2 Blander, D.S., Mark. G.P., HerAandez, L. and Hoebel,
B.G., Anpotensin and drinking induce doptmine relesse
in the nucleus aaumbees, Soc. Netuoacr. Abstr., 14 (1968)
3527.
3 Chan;, V.C., Mark. G.P.. Hernandez, L. and Hoebel.
B.G.. EslraceUular dopamiee incrt:ase to tise nudevs ae
cuatbers following rehYdruioa or sodium repietioa in rats,
Soc. Nesvoui. Abra., 14 (1968) 3527.
4 Di Chiara, G. and Imperato, A., Ethanol prefsrsatially
stimulates dopaaune rokase in the nudeus Bocumbem o(
fmly worn2 nts, Ew. J. PN.nnwol., 113 (19aS)
131-132.
3 Di Chiara. G. and Imperato, A., Drugs abired by bmsm
prtferentiaUy iaaeaee sraaptie dopaeeins ooooeatrarioas
in the mesolimbic sritem of freely atorinS tatt, rroc. Naet.
AaI. Sef. U.S.A., tS (19N)3274-s27a.
6 Dworkin, S.L, Go.dertc, N.E. n.d Smith,l.E.. Is lWdo~.t
turimu on Dnq Abwt Ra.rtb MawjrqA Se+ie:, 67,
trobkrv of Dnej DePwAlwcr, U.S. Publie HeahS Ssrvirs.
1963, pp. l6-144.
7 Haaaa, H.M., Iwaeer, C.A. a.d h/orto., B.R., Ia Nrion
-
.f lwrdnue oe Drrq AMue Rae.rdt Moraojr.pb Series, 2J.
U.S. Pubtic Health Serriee.1979.
E Heraaada, L., Atierb.cit. S. and Hoebel, B.G., Pbeery-
didine (PCt) iajeeted in the tsudeus Bavmtxsis iaaaaes
aaraaellular dopamioe and aetosonin ac meawrad by mi-
ctodialysit. [iJt Scr., 42 (19li)1713-1723.
9 Heraandez. L. aard Hotbel, B.G., Food re.nrd and co-
aine increase artrsodlular dop.mine in the nudeua ae-
cumbees as eeamred by asnsodiatysis, Life Sci.. 42 (19l8)
1705-1712.
10 Hernandez. L. and Hoebel. B.G.. Feeding and hypotha-
lantic uimulation utereaae dopantine tutt+over ia the aca+sr
beut, Phr:iol. ddi.v., in ptess.
367
suits show both disparities and similarities between
nicotine and other drugs of abuse. Intra-accutnbens
nicotine did not affect DOPAC or HVA; wbereas io-
cal amphetamine, cocaine, and phencydidine de
creased DOPACr.'.tt. 'Tbis suggests that nicotine
does not act as a reuptake blocker. The overriding
similarity between nicotine and other drugs of abuse
such as amphetaminelt, phencyclidinei, alcohol',
aAd ooairte' is that they all increase extracellular
dopafnine in the a=umbettss. Food, too, has this ef-
fect'.lo.l', as do some other natural rewards such as
water and Salt", sugjesting that nicotine could sub-
stitute for food and some other natural reinforcets in
this regard. Conversely, animals or people under-
going nicotine withdrawal may substitute food for
nicotine and thereby overeat. In any case, it is clear
that nicotine can have a local action on DA neuro-
transmission in the mesolintbic system.
We thank Kenneth Kellar for advice and Dawn
Davidson for technical assistance. Tbis research was
supported by USPHS Grant DA-03597 to B.G.H.
and Rhone-Poulenc Inc. support for 1.-C.M.
1I Hernandez. L.. Les, F. and Hoebel, B.G., Simultatmosn
miarodialyus and ataphetamine tnfusioe ia the nudeus ae-
cvmbens and uriatum of freely enovinS rats: inaease in a-
traeeliulu dopamine and serotonia, Br.irt Ra. OWL, 19
(19a?)623-62d.
12 Hernandez, L.. Rada, P. and Hoebel, B.G., Mierodia)nis
tatM'sque for sitnultaneous ssses>mant of dopatniae fuae
tio4 ia three ditterent tetmiaal 5eida (unpublisltsd).
13 Herttandez. L.. Sunley, B.G. and Hosbel, B.G., A amall,
reawvable mmodiaryrds peobe, 1,iJe Sd., 39 (1966)
2629-2637.
14 Hoebel, B.G.. Moasco, A.P., Hernanda, L.. Auiisai, E.,
Stanley. B.G. and Lenud, L. Settiajeoawa of ampbeta-
miee direNy into the brai., Pzrdropien.eodoV , 11
(19113)156-163.
15 Imperato, A.. MuW, A. sad Di Cliara, G., Nioooae pW-
ereatiaUy stimulates dopamias eslwe in the limbic trysttm
of freely aartng rata, Eiv. !. Plrmw.cW., 132 (1966)
337-33a.
16 RadAakishsa. F.S., ra. Rse.1.M. asd weatstiek, B.H.C.,
Scheduled eating inereaies dop.mirie teJelae in the atsdeua
aocumbens of food depnved tas rs arrwd Mritb ot.ai.e
.uaodiatvsis. Nervosci. Ler., tS (19q) 331-356.
17 Romano. 0. and Goldpsia, A., Stetraaped6e aiootine ro-
ceptors on rat btai. ae.br~. Satase:, 210 (1910)
N7-6S0.
18 Taylor. P., Ganglionie sasttdatiaS and ttiodciaS aBsats. Ia
A.G. Giltman. L. Goadmaa, T.W. RaY atsd F. Murad
(Eda. ).17re PAsr+wafotiaiJ d.eir oJ?itier.pwier, MaMil-
Iau. New York,19RS.
19 Westfall. T.C., EHeet of lieoti=e aid other drugs oa the rr-
karc of 1HnoreptkpArme aa0 JH-dopramiee froea rat
t>fai.n tlices. NewopM.rnuoeJoV,13 (1974) 693-700.
20 Yos?uda. K. aad Imura. H.. Niootinie, dsobnerpc ttap-
ton in bnia syaal+toaoiaes. 3min Roevc>r, 172 (1979)
4S3-iS9.
I
